JDD June Issue Highlights
Here are the June JDD Issue Highlights:
Guest Editor Dr. James Q. Del Rosso stresses that even the best case scenario of teledermatology can never offer the same as a live in-person visit in Virtual Exams No Substitute for In-Person Care of Acne and Rosacea.
Treating Inflammation in Rosacea: Current Options and Unmet Needs, authors discuss the underlying inflammatory nature of rosacea, tre …
Here are the June JDD Issue Highlights:
Guest Editor Dr. James Q. Del Rosso stresses that even the best case scenario of teledermatology can never offer the same as a live in-person visit in Virtual Exams No Substitute for In-Person Care of Acne and Rosacea.
Treating Inflammation in Rosacea: Current Options and Unmet Needs, authors discuss the underlying inflammatory nature of rosacea, tre … 
Here are the issue highlights and editor picks for JDD's May issue:
Broad area ALA may be beneficial for prevention of new or recurrent lesion formation in patients at high risk for AK and NMSC in A Randomized Trial of Broad Area ALA–PDT for Field Cancerization Mitigation in High-Risk Patients.
Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Tre … 
These are the issue highlights from the March issue of the JDD!
Azelaic acid 15% foam may be an efficacious therapy for rosacea while also offering a better side effect profile in Rosacea Treatment Satisfaction: Matching Adjusted Indirect Treatment Comparison Analysis of Metronidazole Gel or Cream vs Azelaic Acid Foam.
Nail Surgery Myths and Truths dispels common myths encount … 
Spectroscopic data and immunohistochemistry indicate an effect of PLE in Oral Polypodium Leucotomos Extract and Its Impact on Visible Light-Induced Pigmentation in Human Subject.
Authors review available information as well as recent recommendations for treatment in Truncal Acne: A Neglected Entity.
An expert panel of physicians involved in the care of patients with DM exploresDM-associa … 
Here are the issue highlights for the October issue of JDD!
Characterizing how AD patients are currently treated may build a reference for future clinical research in Prescribing Patterns for Atopic Dermatitis in the United States.
A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old explores early intervention in infants and you … 